22 December 2020

Werner Koopman, theme Metabolic Diseases, received 250K Euro as a member of the CureMILS consortium. The latter is funded by the European Joint Programme on Rare Diseases (EJP-RD), which brings together over 130 institutions from 35 countries and focuses on pre-clinical research to develop effective therapies for rare diseases.

The project will run for three years, receiving a total of 2.4 million Euro in funding, and will apply a cell-based reprogramming strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh Syndrome.

CureMILS involves eight academic partners from Germany (Heinrich Heine University, Duesseldorf; Fraunhofer IME, Hamburg), Austria (Innsbruck University), The Netherlands (Radboudumc), Finland (University of Helsinki), Poland (Institute of Genetics and Animal Biotechnology, Jastrzebiec), Italy (Verona University) and Luxemburg (University of Luxembourg). Other participants include various collaborators (Germany, Austria and Italy) and a patient organization (International Mito Patients; IMP).

At Radboudumc, CureMILS will be carried out in a collaborative effort between the groups of Werner Koopman  and Nael Nadif Kasri.


Related news items

Joint research in regional hospitals New research projects from promotion fund

22 November 2022

Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.

read more

New genetic defect links cell biology and protein glycosylation

10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read more

Newborn screening in sight through the discovery of novel disease biomarkers by new technique

8 July 2021 To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, Karlien Coene and colleagues joined forces with scientists at the Radboud University’s FELIX laser laboratory. They published their findings in The Journal of Clinical Investigation. read more

Miniaturized microfluidic platform for automated epigenetic profiling

6 May 2021 Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies. read more

New way of diagnostics detects 'undetectable' genetic defects

15 April 2021

Research provides guidance for global application

read more

Cooling strategies for COVID-19 health personnel to attentuate PPE-induced heat strain

11 June 2020 Radboudumc develops infographic with cooling information read more